Skip to main content
Top
Published in: Pituitary 2/2012

01-06-2012

Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas

Authors: L. G. Sobrinho, J. S. Duarte, I. Paiva, L. Gomes, V. Vicente, P. Aguiar

Published in: Pituitary | Issue 2/2012

Login to get access

Abstract

It has been reported that women with prolactinoma were exposed, early in life, to an environment characterized by an absent or violent father. The present study was designed to evaluate whether paternal absence or violent paternal behavior were more prevalent in patients with pituitary adenomas (prolactinoma, acromegaly, non-secreting adenoma and Cushing’s disease) compared to a control population. We conducted an observational case–control multicenter study. We interviewed 395 patients with prolactinoma (296 females and 99 males), 130 with acromegaly (87 females and 43 males), 237 with non-secreting adenoma (144 females and 93 males) and 68 with Cushing’s disease (61 females and 7 males) and 365 patients from the same clinics with nodular thyroid disease or lymphocytic thyroiditis with euthyroidism as controls. Violent or absent fathers were significantly more prevalent in patients with prolactinoma or acromegaly than in controls (P = 0.001 and P = 0.002, respectively) but not in patients with non-secreting adenoma or corticotrophinoma. Absent fathers in prolactinoma and acromegaly versus controls: P = 0.001 and P = 0.119. Violent fathers in prolactinoma and acromegaly versus controls: P = 0.069 and P = 0.001. The prevalence of absent or violent fathers was also significantly higher in prolactinoma and acromegaly when compared to non-secreting adenoma (P = 0.039 and P = 0.033, respectively). Paternal deprivation before adolescence may be a risk factor for prolactinoma and acromegaly but not for non-secreting pituitary adenomas or Cushing’s disease.
Literature
1.
go back to reference Nunes MCP, Sobrinho LG, Calhaz-Jorge C, Santos MA, Mauricio JC, Sousa MFF (1980) Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea. Obstet Gynecol 55:591–595PubMed Nunes MCP, Sobrinho LG, Calhaz-Jorge C, Santos MA, Mauricio JC, Sousa MFF (1980) Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea. Obstet Gynecol 55:591–595PubMed
2.
go back to reference Rojas LM, Sthory I, Canales ES, Zarate A (1981) Psychogenic factors in the syndrome of amenorrea-galactorrhea. Ginecologia y Obstetricia de Mexico 49:294–295 Rojas LM, Sthory I, Canales ES, Zarate A (1981) Psychogenic factors in the syndrome of amenorrea-galactorrhea. Ginecologia y Obstetricia de Mexico 49:294–295
3.
go back to reference Jürgensen O, Barde B (1983) Psychodynamic findings in women with elevated serum prolactin. In: Dennerstein L, de Senarclens M (eds) The young woman. Psychosomatic aspects of obstetrics and gynecology. Excerpta Medica, I.C.S. 618, Amsterdam, p 120–148 Jürgensen O, Barde B (1983) Psychodynamic findings in women with elevated serum prolactin. In: Dennerstein L, de Senarclens M (eds) The young woman. Psychosomatic aspects of obstetrics and gynecology. Excerpta Medica, I.C.S. 618, Amsterdam, p 120–148
4.
go back to reference Sobrinho LG, Nunes MCP, Calhaz-Jorge C, Afonso AM, Pereira MC, Santos MA (1984) Hyperprolactinemia in women with paternal deprivation during childhood. Obstet Gynecol 64:465–468PubMed Sobrinho LG, Nunes MCP, Calhaz-Jorge C, Afonso AM, Pereira MC, Santos MA (1984) Hyperprolactinemia in women with paternal deprivation during childhood. Obstet Gynecol 64:465–468PubMed
5.
go back to reference Assies J, Vingerhoets AJJM, Poppelaars K (1992) Psychosocial aspects of hyperprolactinemia. Psychoneuroendocrinology 17:673–679PubMedCrossRef Assies J, Vingerhoets AJJM, Poppelaars K (1992) Psychosocial aspects of hyperprolactinemia. Psychoneuroendocrinology 17:673–679PubMedCrossRef
6.
go back to reference Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6:35–39PubMedCrossRef Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6:35–39PubMedCrossRef
7.
go back to reference Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC (2010) Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67:113–123PubMedCrossRef Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC (2010) Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67:113–123PubMedCrossRef
8.
go back to reference Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612PubMedCrossRef Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612PubMedCrossRef
9.
go back to reference Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ (2002) Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973–981PubMed Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ (2002) Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973–981PubMed
10.
go back to reference Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone–producing tumors: clinical, biochemical and morphological manifestations. Endocr Rev 9:357–373PubMedCrossRef Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone–producing tumors: clinical, biochemical and morphological manifestations. Endocr Rev 9:357–373PubMedCrossRef
11.
go back to reference Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Althoff PH, Moore C (1996) Pituitary corticotroph adenoma in a woman with long-standing Addison’s disease: A histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 7:91–97PubMedCrossRef Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Althoff PH, Moore C (1996) Pituitary corticotroph adenoma in a woman with long-standing Addison’s disease: A histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 7:91–97PubMedCrossRef
12.
go back to reference Buurman H, Sager W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef Buurman H, Sager W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef
13.
go back to reference Melmed S, Kleinberg D (2008) Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders, Philadelphia, pp 155–261 Melmed S, Kleinberg D (2008) Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders, Philadelphia, pp 155–261
14.
go back to reference Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney M (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277:1659–1662PubMedCrossRef Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney M (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277:1659–1662PubMedCrossRef
15.
go back to reference McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348PubMedCrossRef McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348PubMedCrossRef
17.
go back to reference Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA (2004) Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol 151:61–65PubMedCrossRef Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA (2004) Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol 151:61–65PubMedCrossRef
18.
go back to reference Sonino N, Fava GA, Grandi S, Mantero F, Boscaro M (1988) Stressful life events in the pathogenesis of Cushing’s syndrome. Clin Endocrinol 29:617–623CrossRef Sonino N, Fava GA, Grandi S, Mantero F, Boscaro M (1988) Stressful life events in the pathogenesis of Cushing’s syndrome. Clin Endocrinol 29:617–623CrossRef
19.
go back to reference Sobrinho LG, Simoes M, Barbosa L, Raposo JF, Pratas S, Fernandes PL, Santos MA (2003) Cortisol, prolactin and growth hormone responses to emotions elicited during an hypnoidal state. Psychoneuroendocrinology 28:1–17PubMedCrossRef Sobrinho LG, Simoes M, Barbosa L, Raposo JF, Pratas S, Fernandes PL, Santos MA (2003) Cortisol, prolactin and growth hormone responses to emotions elicited during an hypnoidal state. Psychoneuroendocrinology 28:1–17PubMedCrossRef
20.
go back to reference Sobrinho LG (1991) Neuropsychiatry of prolactin: causes and effects. Baillière’s Clin Endocrinol Metab 5:119–141CrossRef Sobrinho LG (1991) Neuropsychiatry of prolactin: causes and effects. Baillière’s Clin Endocrinol Metab 5:119–141CrossRef
21.
go back to reference Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-López P, Gálvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naïve acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-López P, Gálvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naïve acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef
22.
go back to reference Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross sectional study in 81 acromegalic patients. Clin Endocrinol 71:691–701CrossRef Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross sectional study in 81 acromegalic patients. Clin Endocrinol 71:691–701CrossRef
23.
go back to reference Tiemensma J, Nienke R, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning in patients after long term cure of acromegaly. J Clin Endocrinol Metab 95: E392-E402. doi:10.1210/jc.2010-1253 Tiemensma J, Nienke R, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning in patients after long term cure of acromegaly. J Clin Endocrinol Metab 95: E392-E402. doi:10.​1210/​jc.​2010-1253
Metadata
Title
Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas
Authors
L. G. Sobrinho
J. S. Duarte
I. Paiva
L. Gomes
V. Vicente
P. Aguiar
Publication date
01-06-2012
Publisher
Springer US
Published in
Pituitary / Issue 2/2012
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0324-1

Other articles of this Issue 2/2012

Pituitary 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.